14 Mid Cap Stocks Just Made New 52-Week Highs
As of Tuesday, October 27, there are 14 Mid Cap US and Canada-listed stocks in the Trefis coverage universe trading at their 52-week highs. Mid Cap here means a market value between $10 billion and $40 billion, the upper figure excluded.
At about $33.9 billion in market value, Mettler-Toledo International (MTD) is the largest company on the list; its stock is up 9.1% over the past month and up 17.5% over the past year. By sector, Health Care leads the list with 7 of the 14 names. For context, the S&P 500 is up 0.6% over the past month, including dividends.
The 10 Largest, By Market Cap
The table below shows the 10 largest of the 14 names, sorted by market capitalization, with returns over four windows:
| Tickers | Market Cap |
1D Return |
1W Return |
1M Return |
1Y Return |
|---|---|---|---|---|---|
| MTD | $33.9 Bil | 0.9% | 3.1% | 9.1% | 17.5% |
| WST | $28.2 Bil | 0.9% | 2.4% | 6.0% | 34.3% |
| RBRK | $28.0 Bil | 1.8% | 18.5% | 20.0% | 76.3% |
| EXPD | $26.1 Bil | 1.6% | 0.6% | 5.9% | 71.2% |
| RS | $22.1 Bil | 2.6% | 3.7% | 10.5% | 58.5% |
| VTRS | $21.8 Bil | 2.4% | 0.4% | 2.5% | 87.3% |
| RVTY | $18.1 Bil | 0.9% | 3.8% | 7.2% | 64.1% |
| CRL | $17.2 Bil | 0.4% | 13.8% | 21.8% | 82.1% |
| HAS | $16.8 Bil | 0.3% | 8.0% | 32.3% | 59.3% |
| EXEL | $16.4 Bil | 0.4% | 1.5% | 12.0% | 68.8% |
Strong Prices, But How Strong Are The Businesses?
Mettler-Toledo International (MTD) trades at 37.4 times trailing earnings, grew revenue 6.9% over the last twelve months and earned an operating margin of 28.4%.
West Pharmaceutical Services (WST) trades at 49.9 times trailing earnings, grew revenue 12.4% over the last twelve months and earned an operating margin of 21.7%.
Across the list, one-month moves range from +2.5% for Viatris (VTRS) to +48.9% for Range Resources (RRC).
The median stock on the list is up 61.7% over the past year.
8 of the 14 names are also S&P 500 members.
Before chasing any name on this list, ask what the company itself expects next. Our Guidance Momentum screen surfaces the stocks whose managements just raised their own outlooks.
Strength Is A Clue. It Is Not A Plan
A stock at its 52-week high has momentum on its side, and momentum is a real force. It is also the most crowded signal in the market, and what separates a run that lasts from one that tops is usually the business underneath.
Checking that business, across thousands of names, is how the Trefis High Quality (HQ) Portfolio is assembled: roughly 30 companies that pass the quality screens, rebalanced on rules. It has a track record of outpacing a benchmark that combines the S&P 500, the S&P MidCap 400, and the Russell 2000. Let the highs point; let the discipline decide.